These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera. Malm M; Tamminen K; Vesikari T; Blazevic V Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization. Malm M; Vesikari T; Blazevic V Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058 [TBL] [Abstract][Full Text] [Related]
6. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs. Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797 [TBL] [Abstract][Full Text] [Related]
7. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes. Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474 [TBL] [Abstract][Full Text] [Related]
8. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein. Malm M; Tamminen K; Vesikari T; Blazevic V Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255 [TBL] [Abstract][Full Text] [Related]
9. Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice. Huo Y; Wan X; Ling T; Wu J; Wang Z; Meng S; Shen S Mol Immunol; 2015 Dec; 68(2 Pt A):367-72. PubMed ID: 26375574 [TBL] [Abstract][Full Text] [Related]
10. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial. Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642 [TBL] [Abstract][Full Text] [Related]
11. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus. Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726 [TBL] [Abstract][Full Text] [Related]
13. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus. Ma Y; Li J J Virol; 2011 Mar; 85(6):2942-52. PubMed ID: 21228240 [TBL] [Abstract][Full Text] [Related]
14. Genetic and antigenic diversity among noroviruses. Hansman GS; Natori K; Shirato-Horikoshi H; Ogawa S; Oka T; Katayama K; Tanaka T; Miyoshi T; Sakae K; Kobayashi S; Shinohara M; Uchida K; Sakurai N; Shinozaki K; Okada M; Seto Y; Kamata K; Nagata N; Tanaka K; Miyamura T; Takeda N J Gen Virol; 2006 Apr; 87(Pt 4):909-919. PubMed ID: 16528040 [TBL] [Abstract][Full Text] [Related]
15. Production, characterization and immunogenicity of P particles derived from norovirus GII.4 genotype 2004 variant. Su W; Gao J; Zang Y; Wu H; Wang L; Hu H; Yu X; Kong W; Jiang C Acta Virol; 2015 Mar; 59(1):33-9. PubMed ID: 25790049 [TBL] [Abstract][Full Text] [Related]
17. A Luciferase Immunoprecipitation System (LIPS) assay for profiling human norovirus antibodies. Tin CM; Yuan L; Dexter RJ; Parra GI; Bui T; Green KY; Sosnovtsev SV J Virol Methods; 2017 Oct; 248():116-129. PubMed ID: 28673856 [TBL] [Abstract][Full Text] [Related]
18. The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics. van Loben Sels JM; Green KY Viruses; 2019 May; 11(5):. PubMed ID: 31083353 [TBL] [Abstract][Full Text] [Related]